Cyclobenzaprine hydrochloride and Pyridium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cyclobenzaprine hydrochloride (cyclobenzaprine hydrochloride) and Pyridium (phenazopyridine hydrochloride). Common drug interactions include foot fracture among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cyclobenzaprine hydrochloride and Pyridium. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Cyclobenzaprine hydrochloride?

Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 9,352 Cyclobenzaprine hydrochloride users. Check the latest studies of Cyclobenzaprine hydrochloride.

What is Pyridium?

Pyridium has active ingredients of phenazopyridine hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 1,841 Pyridium users. Check the latest studies of Pyridium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

15 people who take Cyclobenzaprine hydrochloride and Pyridium together, and have interactions are studied.

Cyclobenzaprine hydrochloride and Pyridium drug interactions.

What are the common drug interactions of Cyclobenzaprine Hydrochloride and Pyridium, by gender? *:

female:

  1. Foot fracture
  2. Hospitalisation
  3. Infected cyst
  4. Infusion site reaction
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Pericardial effusion (fluid around the heart)
  9. Pyrexia (fever)
  10. Bone disorder

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Diarrhoea
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the common drug interactions of Cyclobenzaprine Hydrochloride and Pyridium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)

40-49:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Cardiac disorder
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Ear infection
  5. Foot fracture
  6. Infected cyst
  7. Infusion site reaction
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Nephrolithiasis (calculi in the kidneys)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Hip arthroplasty

60+:

  1. Bone disorder
  2. Chronic kidney disease
  3. Pathological fracture (broken bone caused by disease)
  4. Renal failure (kidney dysfunction)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Fall
  8. Femur fracture
  9. Joint instability (a condition in which the joints aren't sufficiently supported)
  10. Low turnover osteopathy (slow removal of old bone and its replacement by new bone)

What are the existing conditions these people have? *

  1. Pain: 6 people, 40.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 33.33%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 33.33%
  4. Depression: 4 people, 26.67%
  5. Cardiac Disorder: 3 people, 20.00%
  6. Indigestion: 3 people, 20.00%
  7. Immunodeficiency Common Variable: 2 people, 13.33%
  8. Asthma: 2 people, 13.33%
  9. Sinus Disorder (disease of sinus): 2 people, 13.33%
  10. Bladder Disorder: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclobenzaprine hydrochloride and Pyridium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cyclobenzaprine hydrochloride and Pyridium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cyclobenzaprine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pyridium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclobenzaprine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pyridium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and phenazopyridine hydrochloride (the active ingredients of Cyclobenzaprine hydrochloride and Pyridium, respectively), and Cyclobenzaprine hydrochloride and Pyridium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: